fbpx

Brain cancer

ur group work on Glioblastoma, an incurable form of brain cancer with the average survival rate of only 12-15 months post diagnosis.   This is largely due to the ability of these brain tumour cells to block the function of the immune system and thereby escape being killed by these immune cells. However, how these […]

Read More…

Immunology

Our research is focused on the role of the immune system and how it relates and can be used to treat cancer. In the future, cancer will predominately be treated with the activation of the immune system, without chemotherapy and radiation. We are undertaking studies on the immunology of cancer and the role of T […]

Read More…

Ovarian Cancer

Every 11 hours one woman dies of ovarian cancer in Australia. Approximately 1400 Australia women are diagnosed with the cancer each year, and nearly 800 die annually, making ovarian cancer the fourth most common cause of cancer-related death in women in Australia. The high mortality rate in ovarian cancer patients results from the diagnosis of […]

Read More…

Langerhans Cell Histocytosis

LCH is a rare cancer-like disease that mostly affects infants and children but can also occur in adults. Lesions can infiltrate any organ of the body, which can result in bone lesions and scarring of vital organs. Our research has the potential to unlock broad new findings to better understand LCH and other diseases involving […]

Read More…

Chronic Lymphocytic Leukemia (CLL)

CLL is the most common type of leukemia in adults in the Western world. There is evidence that genetic components contribute to the aetiology of CLL, but no definitive susceptibility genes have been identified. This project is studying the role of immune cells in the regulation of disease progression. The Institute is in a unique […]

Read More…

Breast cancer

Fiona Elsey Cancer Research Institute’s Breast cancer research group is a great example of some of the important work that is being delivered in Ballarat. Thegroup is focussed on the immunology of Breast cancer with special reference to high-risk triplenegative breast cancer. Dr Aparna Jayachandran is the Senior Research Fellow, leading the Breast cancer program […]

Read More…

Bowel cancer

Bowel cancer research conducted at the Fiona Elsey Cancer Research Institute in Ballarat, has discovered that a subset of immune cells in the bowel can misbehave and release chemical messengers that promote bowel cancer and inhibit other immune cells. Australia has one of the highest rates of Bowel cancer in the world. It is the […]

Read More…

Renal cancer

The role of immune cells in renal cancer and genito-urinary cancer is led by Dr Prashanth Prithviraj and Professor Nuzhat Ahmed. The group are studying the role of Epithelial to Mesenchymal Transformation (EMT) in these cancers with the view of using this information to enhance treatments in these cancers. Renal cancer is cancer of the […]

Read More…